AMT

Canonical status: prohibited under Austria's SMG/SV controlled-substance route. AMT is identified by the current Austrian ministry directory as an isomer of 5-(2-Aminopropyl)indol, which is listed in SV Annex V.1, and SV §1(4) extends Suchtgift treatment to structurally similar positional isomers with comparable pharmacological effect. SV §2 authorization rules and SMG §27 unauthorized-handling penalties apply subject to statutory exceptions and purpose-specific provisions. NPSV Annex II no. 6 overlaps nominally with the tryptamine class, but NPSG §2(2) excludes substances subject to the SMG; the sources therefore do not support a blanket claim that every possession, production or sale is prohibited identically.

Canonical status: prohibited. AMT is expressly listed as item 99 in China's current 2025 Non-medical Narcotic and Psychotropic Drugs Directory, which took effect on publication and replaced the former supplementary directory. The current consolidated regulation permits experimental research only under its conditions and approval requirements, and prohibits ordinary production, operation, use, storage and transport. Import/export is governed by applicable separate laws under Article 2; no broader import/export prohibition is inferred here.

Greece's Ministry of Health current controlled-substance table identifies A-MT (Alpha-methyltryptamine / Αλφα-μεθυλοτρυπταμίνη) in Table A and traces the entry to Law 3459/2006, FEK A 103/25 May 2006. The official National Printing Office Gazette scan of Law 3459/2006 Table A independently prints the exact identity and distinguishes it from DMT and 5-MeO-AMT. Under Law 4139/2013 Article 1(2), the A–D tables are those of Law 3459/2006 as amended under its delegated authority. Article 2(1) makes production, possession, transport, storage, procurement, processing, circulation and any intermediation in circulation of Table A substances an exclusive State right exercised through EOF; Table A substances may be supplied only to laboratories or hospitals for approved programmes after Narcotics Committee opinion. Article 2(5) requires a Ministry of Health decision after Narcotics Committee opinion for import/export. Article 20(1)-(2) treats unauthorized trafficking broadly (including import, export, sale, purchase, offer, distribution, supply, shipment, delivery, storage, manufacture, possession and transport) and provides at least eight years' imprisonment plus a fine up to EUR 300,000, subject to Articles 21–23 and Article 29. Article 21 provides a specific up-to-three-year imprisonment route for an addicted person handling small quantities for daily personal needs and for specified no-profit transfers for personal use. Article 22 raises aggravated cases to at least ten years plus EUR 50,000–500,000; Article 23 provides life imprisonment or at least ten years plus EUR 50,000–600,000 (or up to EUR 1,000,000 for specified professional/weapon cases). Article 29 provides up to five months for procurement, possession or use solely for personal use, with the statutory fact-specific personal-use test and treatment provisions. These are criminal-law provisions, not a lawful consumer or recreational allowance; charging and sentence depend on conduct, quantity, purpose, dependency, aggravating facts and applicable statutory exceptions.

The current consolidated Order No. 5 (effective 2025-06-18) places the tryptamine/bioisostere group in List I, defined as narcotic and psychotropic substances prohibited for medical use except where a List-I substance is in a registered medicinal product. Its point 137 rule covers 2-(1H-indol-3-yl)ethanamine derivatives with specified ring, amino-group or ethanamine-fragment substituents, including 1-methyl; AMT's official chemical identity is 1-(1H-indol-3-yl)propan-2-amine, so it matches the 1-methyl ethanamine-fragment criterion. The group excludes tryptamine, serotonin and substances in List II, none of which is AMT; possible salts, ethers and esters are controlled identically, and the schedule's general note applies the same regime to isomers and possible derivatives. The group was introduced by Order No. V-449 of 2012-05-18, effective 2012-05-25, supporting the legacy entry's 2012 timing. Order V-239's current point 174 gives the group-level quantity thresholds 0.2 g / 20 g / 100 g; these are charging thresholds, not lawful possession allowances. Under current Criminal Code Article 259, unlawful manufacture, processing, acquisition, possession, transport or forwarding without distribution intent is punishable by a fine, arrest or imprisonment up to two years; small-quantity conduct is a criminal misdemeanour punishable by community service, restriction of liberty, a fine or arrest. Article 259(3) provides conditional relief for voluntary medical help or surrender to a state institution. Article 260 provides 2–8 years for distribution-intent handling or distribution, 8–10 years for large quantities with distribution intent/distribution, and 10–15 years for very large quantities; legal persons also incur liability. No ordinary prescription, consumer or recreational exception was found; the registered-medicinal-product qualification and Article 259(3) relief are narrow limitations.

The exact AMT identity is not expressly named in the current Slovak controlled-substance schedule (Act 139/1998 Annex 1). The Annex names other tryptamines, including DET (N,N-diethyltryptamine), DMT (N,N-dimethyltryptamine) and etryptamine, but targeted review found no AMT, alpha-methyltryptamine or generic tryptamine-analogue entry that captures AMT. The current Slovak risk-substance list (Decree 121/2015, as amended, effective 1 November 2018) does contain the visually similar entry "a-MT, system name 2-methyltryptamine". That entry is chemically different from AMT: the Slovak entry identifies a methyl-substituted indole (2-(2-methyl-1H-indol-3-yl)ethanamine), while AMT has a methyl-substituted side chain (1-(1H-indol-3-yl)propan-2-amine). The superseded 2013 risk-substance decree likewise listed "a-MT" as 2-methyltryptamine from 1 October 2013, but that decree was expressly repealed by Decree 121/2015. Section 16a of Act 139/1998 defines risk substances, provides for their listing when there is a substantiated suspicion of harmful misuse, and requires a substance shown to have narcotic/psychotropic properties to be moved into Annex 1; the reviewed text does not itself impose the Annex 1 controlled-substance licensing or criminal regime merely from a risk-list entry. For substances actually in Annex 1, Section 3 assigns one of three groups and Section 4 requires authorization for handling; Group I substances may be handled only for research, teaching or expert purposes, while unauthorized handling is defined by Section 4(4). The Criminal Code penalties are conditional on the material being an omamná or psychotropná látka: Section 171 provides up to two years for unauthorized possession of a non-cannabis/non-THC drug in a negligible amount, six months to three years for a small amount, and one to six years for recidivism or a larger amount; Section 173 provides one to five years for unauthorized manufacture or trafficking in a negligible amount, with higher tiers (three to ten, seven to fifteen, eight to twenty, and ten to twenty-five years or life) for specified amount, aggravating, consequence and organized-crime circumstances. Act Section 39 also provides administrative fines up to EUR 16,596 or EUR 33,193 for breaches of listed obligations, but those obligations concern authorized handling of substances governed by the Act and do not independently establish a penalty for exact AMT absent controlled-substance classification. The original row's statement that AMT was controlled in a 2013 hazardous-substance annex is therefore corrected: the official 2013 and current risk lists identify 2-methyltryptamine, not the exact AMT identity.

The latest Spanish psychotropic schedule reviewed is the BOE consolidation of Real Decreto 2829/1977 marked last updated 21 April 2026, together with Orden SND/362/2026 (effective 22 April 2026). Annex 1 is made up of named Lists I-IV and Annex 2 is a named relation of psychotropics outside those lists. The schedule expressly names other tryptamines (DET/N,N-diethyltryptamine, DMT/N,N-dimethyltryptamine and etryptamine), but no AMT/alpha-methyltryptamine entry or generic structural-analogue rule was found. Therefore AMT is reported as unscheduled under the named Spanish psychotropic schedules, not as legal regulated or analog-covered. This does not guarantee that every conduct is lawful: Penal Code article 368 can apply if a court and expert evidence treat the substance as a toxic drug, narcotic or psychotropic substance and the conduct is cultivation, manufacture, trafficking, facilitation or possession for those purposes; public illicit consumption or possession is a serious administrative offence under Organic Law 4/2015 article 36.16, punishable under article 39 by a 601–30,000 euro fine. Those provisions do not themselves create a named AMT schedule entry, and the article 368 classification and penalty tier are fact-specific.

The current consolidated 78/2022 BM decree displayed an effective-date snapshot of 2026-06-29. Its 2nd Annex P1 table names AMT (alfa-metiltriptamin) at row 35 and gives the identity 1-(1H-indol-3-yl)propan-2-amine, formula C11H14N2 and InChIKey QSQQQURBVYWZKJ-UHFFFAOYSA-N. This corrects the existing uncited 'Schedule C' wording: the operative current schedule is P1, not the former 66/2012 Korm. rendelet C list. Btk. 459. § (1a) makes P1-listed psychotropics kábítószer for Btk. 176–180 and other enumerated offences. Unauthorized cultivation, production, acquisition, possession, ordering for import, import, export or transit is generally punishable under Btk. 178. § (1) by 2–8 years' imprisonment; aggravated amounts or circumstances raise the range under § 178 (2), while small quantity is addressed in § 178 (5), and consumption or small-quantity acquisition/possession for consumption is punishable under § 178 (6) by up to 2 years. Supply/trafficking is generally 2–8 years under § 176 (1), with higher ranges for significant quantity, organized/aggravated circumstances and special victim/location provisions. Btk. § 180 provides narrowly conditioned non-punishment for qualifying small-quantity own-use conduct or consumption (admission, six months' treatment/service and pre-charge disclosure/identification conditions); it is not a legalization or ordinary possession exception. The consulted current quantity provisions do not state an AMT-specific small-quantity threshold, so amount classification is a material case-specific limitation; no prescription, consumer or recreational market exception was found.

AMT is not printed as a separate named/CAS row in the current Latvian schedule. The official UNODC Laboratory and Scientific Service substance record identifies alpha-methyltryptamine (AMT, α-MT) as 1-(1H-indol-3-yl)propan-2-amine / 3-(2-aminopropyl)indole, assigns it to the Tryptamines group, and gives CAS 879-36-7. That identity has the beta-(indol-3-yl)ethanamine/tryptamine core and a methyl substituent on the ethylene group. Current Annex 2 Chapter II List I paragraph 11 item 8 expressly covers any beta-(indol-3-yl)ethanamine or beta-(benzofuran-3-yl)ethanamine derivative (except serotonin and the specifically named therapeutic triptans) bearing at least one benzene-ring, ethylene-group or amino-group substituent. AMT is not among the listed exceptions, so it is structurally captured in List I. The Legal Circulation Law Section 3(2)-(3) makes Annex 2 the statutory controlled-substance schedule and defines List I as prohibited especially dangerous narcotic substances and equivalent psychotropic substances. Section 5 prohibits cultivation, production, manufacture, import, export, distribution, advertising, transport, storage, transfer for payment or without payment, acquisition, use and transit through Latvia of List I plants, substances and medicines. Section 7 permits a narrow State Agency of Medicines authorization for medical/veterinary scientific research, physical/chemical property determination and training; this is not an ordinary consumer, prescription or recreational exception. Criminal Law Section 253 provides up to three years or alternative sanctions for unauthorized manufacture, acquisition, storage, transportation or forwarding without disposal intent, and three to ten years (with optional confiscation and probation supervision up to three years) for a prior-agreement group or large amount. Section 253.1 provides two to eight years for disposal-intent handling or unlawful disposal, three to ten years for a prior-agreement group, and five to fifteen years (with optional confiscation and probation supervision up to three years) for an organized group, large amount, serious consequences or specified aggravated locations/victims. Section 253.2 provides short-term custody, probation supervision, community service or a fine for warned-person small-amount acquisition/storage without disposal intent or use, and up to three years or alternatives for small-amount disposal-intent handling or disposal. Section 254 provides fact-specific relief from criminal liability where a person voluntarily surrenders or reports the prohibited/limited-circulation substance or helps in an overdose emergency; it does not legalize possession or supply. The 0.02 g and 1 g schedule amounts are criminal-law quantity thresholds, not lawful possession allowances.

AMT is not a prescription or ordinary medical-use substance in Russia. The express AMT List I entry covers the named compound and derivatives, subject to the exception for a derivative that has its own independent schedule entry. Under Federal Law No. 3-FZ Article 14, List I turnover is limited to the purposes and statutory exceptions specified in that law (including destruction, scientific/educational, expert and operational-search purposes); this is not a consumer, recreational or general prescription authorization. Government Decree No. 1002's AMT row sets significant quantity at over 0.5 g, large quantity at over 2.5 g and especially large quantity at over 500 g. For possession, acquisition, storage, transport, manufacture or processing without intent to supply, Criminal Code Article 228 part 1 applies at significant quantity (up to 3 years imprisonment or alternative sanctions), part 2 at large quantity (3–10 years), and part 3 at especially large quantity (10–15 years, with possible additional fine/restriction of liberty). Amounts below the significant threshold may, where the statutory conditions are met, fall under administrative Article 6.8 rather than Article 228; the Supreme Court states that this is not a lawful possession allowance. Supply, production or forwarding is separately punished by Article 228.1; the Supreme Court confirms part 1 applies regardless of quantity and provides 4–8 years, with substantially higher penalties for aggravated conduct. Exact charging depends on measured mass, intent to supply, aggravating facts, and whether a derivative is independently scheduled.